Abellanosa, Crysverlie D.
HRN: 25-65-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/23/2025
01/29/2025
ORAL
1.7
Bid
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes